Unichem plans sale of domestic formulations business; valuation seen at $1-1.2 billion

Medium-sized Indian drugmaker Unichem LabsBSE -0.31 % is exploring the sale of its domestic formulations business. The proposal by one of India’s oldest pharmaceutical companies is at a preliminary stage and is being studied by large strategic investors and private equity firms, several people told ET.Investment bank Jefferies has been hired to seek potential suitors. The valuation could be $1-1.2 billion, said one of those cited above.
Read more at: